HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Goldberg Selected Research

Interleukin-8 (Interleukin 8)

12/2001Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
1/2000Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Goldberg Research Topics

Disease

16Neoplasms (Cancer)
10/2004 - 01/2000
10Carcinoma (Carcinomatosis)
12/2001 - 01/2000
5Neoplasm Metastasis (Metastasis)
10/2004 - 04/2000
3Hyperglycemia
02/2009 - 05/2000
3Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2008 - 10/2000
3Ocular Hypertension (Glaucoma, Suspect)
05/2008 - 10/2000
3Glaucoma
05/2008 - 10/2000
3Pemphigus (Pemphigus Vulgaris)
04/2004 - 01/2001
3Atherosclerosis
07/2003 - 03/2000
2Inflammation (Inflammations)
02/2009 - 08/2001
2Breast Neoplasms (Breast Cancer)
10/2004 - 10/2000
2Ganglion Cysts (Ganglion)
07/2004 - 07/2001
2Infarction (Infarctions)
07/2003 - 12/2001
2Myocardial Infarction
07/2003 - 12/2001
2Adenocarcinoma
11/2001 - 04/2000
1Failure to Thrive
01/2020
1Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
01/2020
1Eosinophilia
06/2019
1Cutaneous Mastocytosis
07/2018
1Ichthyosis (Xeroderma)
01/2012
1Chanarin-Dorfman Syndrome
01/2012
1Factor XI Deficiency (Hemophilia C)
09/2011
1Hemorrhage
09/2011
1Hypersensitivity (Allergy)
09/2011
1Thrombophilia
09/2011
1Drug-Related Side Effects and Adverse Reactions
05/2008
1Hyperpigmentation
05/2008
1Sepsis (Septicemia)
10/2004
1Wilms Tumor (Wilm's Tumor)
10/2004
1Hirschsprung Disease (Hirschsprung's Disease)
07/2004
1Acantholysis
07/2003
1Dyskinesias (Dyskinesia)
12/2001
1Coronary Occlusion
12/2001
1Glioma (Gliomas)
11/2001

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
12/2001 - 01/2000
3LipidsIBA
01/2012 - 06/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003 - 02/2000
3Proteins (Proteins, Gene)FDA Link
12/2001 - 12/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2001 - 01/2000
3Transcription Factors (Transcription Factor)IBA
12/2001 - 05/2000
3Matrix Metalloproteinases (MMPs)IBA
11/2001 - 03/2001
3Cadherins (E-Cadherin)IBA
09/2001 - 12/2000
2Keratins (Keratin)IBA
01/2020 - 06/2000
2AntigensIBA
10/2004 - 04/2000
2AntibodiesIBA
07/2003 - 04/2000
2Phenol (Carbolic Acid)FDA Link
07/2003 - 01/2001
2Peptide Hydrolases (Proteases)FDA Link
07/2003 - 03/2001
2Complement System Proteins (Complement)IBA
07/2003 - 04/2000
2Interleukin-8 (Interleukin 8)IBA
12/2001 - 01/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2001 - 03/2001
2beta CateninIBA
09/2001 - 07/2001
2Type II DNA Topoisomerases (Topoisomerase II)IBA
07/2001 - 03/2000
2gamma Catenin (Plakoglobin)IBA
07/2001 - 12/2000
2ErbB Receptors (EGF Receptor)IBA
05/2001 - 12/2000
2Streptozocin (Streptozotocin)FDA Link
06/2000 - 05/2000
2LDL Receptors (LDL Receptor)IBA
06/2000 - 03/2000
2Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2000 - 03/2000
2oxidized low density lipoproteinIBA
06/2000 - 03/2000
2Monoclonal AntibodiesIBA
04/2000 - 03/2000
1Indicators and Reagents (Reagents)IBA
06/2019
1pimecrolimus (Elidel)FDA Link
07/2018
1AcitretinFDA Link
01/2012
1A-factor (Streptomyces)IBA
09/2011
1Dacarbazine (DIC)FDA LinkGeneric
09/2011
1Factor XI (Plasma Thromboplastin Antecedent)IBA
09/2011
1Fibrinogen (Factor I)FDA Link
02/2009
1C-Reactive ProteinIBA
02/2009
1Glucose (Dextrose)FDA LinkGeneric
02/2009
1LDL CholesterolIBA
02/2009
1Latanoprost (Xalatan)FDA Link
05/2008
1Retinaldehyde (Retinal)IBA
04/2006
1Growth Factor ReceptorsIBA
10/2004
1Calbindin 2IBA
07/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
04/2004
1HLA-B38 AntigenIBA
04/2004
1HLA-B35 Antigen (HLA B35 Antigen)IBA
04/2004
1Plasminogen Activators (Plasminogen Activator)IBA
07/2003
1PhenolsIBA
07/2003
1Sulfhydryl Compounds (Thiols)IBA
07/2003
1Pyridinolcarbamate (P23)IBA
07/2003
1CytokinesIBA
07/2003
1Transforming Growth Factor beta (TGF-beta)IBA
07/2003
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2001
1Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2001
1DNA (Deoxyribonucleic Acid)IBA
12/2001
1Integrin alphaVIBA
12/2001
1DesminIBA
12/2001
1Insulin-Like PeptidesIBA
12/2001
1Troponin IIBA
12/2001
1Integrin beta1IBA
12/2001
1IntegrinsIBA
12/2001
1Methionine (L-Methionine)FDA Link
11/2001
1Tissue Inhibitor of Metalloproteinase-2IBA
11/2001

Therapy/Procedure

5Therapeutics
08/2001 - 05/2000
1Enteral Nutrition (Feeding, Tube)
01/2020
1Arthroplasty
09/2011
1Thyroidectomy
09/2011
1Drug Therapy (Chemotherapy)
10/2004
1Radiotherapy
10/2004
1Ligation
07/2003